Correlation Between Eterna Therapeutics and Traws Pharma

Can any of the company-specific risk be diversified away by investing in both Eterna Therapeutics and Traws Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eterna Therapeutics and Traws Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eterna Therapeutics and Traws Pharma, you can compare the effects of market volatilities on Eterna Therapeutics and Traws Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eterna Therapeutics with a short position of Traws Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eterna Therapeutics and Traws Pharma.

Diversification Opportunities for Eterna Therapeutics and Traws Pharma

-0.33

Correlation Coefficient

Eterna Therapeutics  Traws Pharma

Very good diversification

The 3 months correlation between Eterna and Traws is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Eterna Therapeutics and Traws Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Traws Pharma and Eterna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eterna Therapeutics are associated (or correlated) with Traws Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Traws Pharma has no effect on the direction of Eterna Therapeutics i.e., Eterna Therapeutics and Traws Pharma go up and down completely randomly.

Pair Corralation between Eterna Therapeutics and Traws Pharma

Given the investment horizon of 90 days Eterna Therapeutics is expected to under-perform the Traws Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Eterna Therapeutics is 1.45 times less risky than Traws Pharma. The stock trades about -0.05 of its potential returns per unit of risk. The Traws Pharma is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  1,951  in Traws Pharma on October 4, 2024 and sell it today you would lose (1,084) from holding Traws Pharma or give up 55.56% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Eterna Therapeutics  vs.  Traws Pharma

Eterna Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Eterna Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Traws Pharma

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Traws Pharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Traws Pharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Eterna Therapeutics and Traws Pharma

The main advantage of trading using opposite Eterna Therapeutics and Traws Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eterna Therapeutics position performs unexpectedly, Traws Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Traws Pharma will offset losses from the drop in Traws Pharma's long position.

The idea behind Eterna Therapeutics and Traws Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.